Thomas Bertrand

2.7k total citations · 1 hit paper
24 papers, 1.7k citations indexed

About

Thomas Bertrand is a scholar working on Molecular Biology, Epidemiology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Thomas Bertrand has authored 24 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 5 papers in Epidemiology and 4 papers in Cellular and Molecular Neuroscience. Recurrent topics in Thomas Bertrand's work include Cellular transport and secretion (3 papers), Peptidase Inhibition and Analysis (3 papers) and Protease and Inhibitor Mechanisms (3 papers). Thomas Bertrand is often cited by papers focused on Cellular transport and secretion (3 papers), Peptidase Inhibition and Analysis (3 papers) and Protease and Inhibitor Mechanisms (3 papers). Thomas Bertrand collaborates with scholars based in France, United Kingdom and United States. Thomas Bertrand's co-authors include Pierre Briozzo, Claude Jolivalt, Christian Mougin, Eliane Caminade, Nathalie Joly, Catherine Madzak, Magali Mathieu, Katherine A. Brown, Laurent Schio and Alexey Rak and has published in prestigious journals such as Journal of Biological Chemistry, Nature Medicine and Nature Communications.

In The Last Decade

Thomas Bertrand

24 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A highly potent and selective Vps34 inhibitor alters vesicle trafficking and autophagy

2014 356 citations Baptiste Ronan, Christine Dureuil et al. Nature Chemical Biology profile →

Peers

Countries citing papers authored by Thomas Bertrand

Since Specialization

Citations

This map shows the geographic impact of Thomas Bertrand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Bertrand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Bertrand more than expected).

Fields of papers citing papers by Thomas Bertrand

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Bertrand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Bertrand. The network helps show where Thomas Bertrand may publish in the future.

Co-authorship network of co-authors of Thomas Bertrand

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Bertrand. A scholar is included among the top collaborators of Thomas Bertrand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Bertrand. Thomas Bertrand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Structural insights into epitope-paratope interactions of a monoclonal antibody targeting CEACAM5-expressing tumors 2024 ·Nature Communications ·Anand Kumar, Francis Duffieux, (unknown), Chiara Rapisarda, Thomas Bertrand, Alexey Rak	3
2	KRAS G12C fragment screening renders new binding pockets 2021 ·Small GTPases ·Magali Mathieu, (unknown), Florence Fassy, Cécile Delorme, (unknown), (unknown), Francis Duffieux, Thomas Bertrand, (unknown), (unknown), (unknown), (unknown), J.-P. Marquette, Maryse Lowinski, (unknown), (unknown), Laurent Debüssche, Alexey Rak	15
3	Genetically detoxified pertussis toxin displays near identical structure to its wild-type and exhibits robust immunogenicity 2020 ·Communications Biology ·Salvador F. Ausar, Shaolong Zhu, (unknown), Michael S. Cohen, Thomas Bertrand, (unknown), Derek J. Wilson, Stephen Li, Anthony Sheung, Roger H. Brookes, (unknown), Alexey Rak, D. Andrew James	21
4	A single T cell epitope drives the neutralizing anti-drug antibody response to natalizumab in multiple sclerosis patients 2019 ·Nature Medicine ·Antonino Cassotta, Vincent Mikol, Thomas Bertrand, Stéphanie Pouzieux, (unknown), Paul Ferrari, (unknown), Michael Auer, Florian Deisenhammer, Matteo Gastaldi, Diego Franciotta, Chiara Silacci-Fregni, (unknown), (unknown), Mathilde Foglierini, David Jarrossay, Roger Geiger, Federica Sallusto, Antonio Lanzavecchia, Luca Piccoli	49
5	Crystal Structures of Neurotrophin Receptors Kinase Domain 2016 ·Vitamins and hormones ·Thomas Bertrand	4
6	Tissue-type plasminogen activator controls neuronal death by raising surface dynamics of extrasynaptic NMDA receptors 2016 ·Cell Death and Disease ·Flavie Lesept, (unknown), Julie Jézéquel, Laurent Ladépêche, Richard Macrez, (unknown), Sophie Lenoir, Thomas Bertrand, (unknown), Pascale Galéa, (unknown), Karl‐Uwe Petersen, Yannick Hommet, Eric Maubert, Carine Ali, Laurent Groc, Denis Vivien	43
7	Conformations of tissue plasminogen activator (tPA) orchestrate neuronal survival by a crosstalk between EGFR and NMDAR 2015 ·Cell Death and Disease ·Thomas Bertrand, Flavie Lesept, (unknown), Sophie Lenoir, (unknown), (unknown), Yannick Hommet, Isabelle Bardou, Jérôme Parcq, Denis Vivien	33
8	Urokinase versus Alteplase for intraventricular hemorrhage fibrinolysis 2014 ·Neuropharmacology ·Thomas Gaberel, Axel Montagne, Flavie Lesept, Maxime Gauberti, Eloïse Lemarchand, Cyrille Orset, Romain Goulay, Thomas Bertrand, Évelyne Emery, Denis Vivien	41
9	A highly potent and selective Vps34 inhibitor alters vesicle trafficking and autophagy breakdown → 2014 ·Nature Chemical Biology ·Baptiste Ronan, (unknown), (unknown), Christine Dureuil, Laurence Durand, Florence Fassy, (unknown), (unknown), Magali Mathieu, Thomas Bertrand, J.-P. Marquette, Youssef El‐Ahmad, Bruno Filoche-Rommé, Laurent Schio, Carlos Garcı́a-Echeverrı́a, Hélène Goulaouic, Benoit Pasquier	356
10	Molecular requirements for safer generation of thrombolytics by bioengineering the tissue-type plasminogen activator A chain 2013 ·Journal of Thrombosis and Haemostasis ·Jérôme Parcq, Thomas Bertrand, (unknown), Yannick Hommet, Eduardo Anglés‐Cano, Denis Vivien	23
11	GluN2D Subunit-Containing NMDA Receptors Control Tissue Plasminogen Activator-Mediated Spatial Memory 2012 ·Journal of Neuroscience ·Pauline Obiang, Richard Macrez, Amandine Jullienne, Thomas Bertrand, Flavie Lesept, Carine Ali, Eric Maubert, Denis Vivien, Véronique Agin	22
12	Unveiling an exceptional zymogen: the single-chain form of tPA is a selective activator of NMDA receptor-dependent signaling and neurotoxicity 2012 ·Cell Death and Differentiation ·Jérôme Parcq, Thomas Bertrand, Axel Montagne, (unknown), Richard Macrez, Jean‐Marie Billard, (unknown), Yannick Hommet, Jialing Wu, Manuel Yepes, H.R. Lijnen, P. Dutar, Eduardo Anglés‐Cano, Denis Vivien	57
13	The Crystal Structures of TrkA and TrkB Suggest Key Regions for Achieving Selective Inhibition 2012 ·Journal of Molecular Biology ·Thomas Bertrand, (unknown), (unknown), A. Dupuy, Alexey Rak, Pierre‐François Berne, Samuel Davis, Tatiana Gladysheva, (unknown), (unknown), Magali Mathieu	87
14	Four Distinct Structural Domains in Clostridium difficile Toxin B Visualized Using SAXS 2010 ·Journal of Molecular Biology ·D. Albesa-Jové, Thomas Bertrand, Elisabeth P. Carpenter, (unknown), Jenson Lim, Jiancheng Zhang, L.F. Haire, N. Vasisht, Veit Braun, (unknown), Christoph von Eichel‐Streiber, Dmitri I. Svergun, Neil F. Fairweather, Katherine A. Brown	46
15	Structural Basis for Human Monoglyceride Lipase Inhibition 2009 ·Journal of Molecular Biology ·Thomas Bertrand, Franck Augé, (unknown), Alexey Rak, François Vallée, V. Mikol, Pierre‐François Berne, Nadine Michot, (unknown), Chloé Hoornaert, Magali Mathieu	128
16	Structural and functional consequences of single amino acid substitutions in the pyrimidine base binding pocket of Escherichia coli CMP kinase 2007 ·FEBS Journal ·(unknown), Nadia Bucurenci, Emil Alexov, Thomas Bertrand, Pierre Briozzo, Hélène Munier‐Lehmann, Anne‐Marie Gilles	11
17	Crystal Structure of Mycobacterium tuberculosis Catalase-Peroxidase 2004 ·Journal of Biological Chemistry ·Thomas Bertrand, Nigel A. J. Eady, Jamie N. Jones, Jesmin Jesmin, Judit Nagy, Brigitte Jamart‐Grégoire, Emma Lloyd Raven, Katherine A. Brown	164
18	Deciphering the function of an ORF: Salmonella enterica DeoM protein is a new mutarotase specific for deoxyribose 2004 ·Protein Science ·Liliane Assairi, Thomas Bertrand, (unknown), (unknown), Mette Christensen, Pierre Briozzo, Francis Schaeffer, Constantin T. Craescu, Jan Neuhard, Octavian Bârzu, Anne‐Marie Gilles	5
19	Sugar specificity of bacterial CMP kinases as revealed by crystal structures and mutagenesis of Escherichia coli enzyme 2002 ·Journal of Molecular Biology ·Thomas Bertrand, Pierre Briozzo, Liliane Assairi, (unknown), Nadia Bucurenci, Hélène Munier‐Lehmann, Béatrice Golinelli‐Pimpaneau, Octavian Bârzu, Anne‐Marie Gilles	26
20	Purification and preliminary crystallographic study ofTrametes versicolorlaccase in its native form 2002 ·Acta Crystallographica Section D Biological Crystallography ·Thomas Bertrand, Claude Jolivalt, Eliane Caminade, Nathalie Joly, Christian Mougin, Pierre Briozzo	23

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact